AGP Wire
Stay informed with articles highlighting the latest developments, major events, and essential updates.
Civil aerospace simulation market seen reaching $5.8B by 2030
AGP
The civil aerospace simulation and training market is projected to grow from $4.38 billion in 2026 to $5.8 billion by 2030, driven by pilot shortages, rising air traffic and demand for lower-cost training tools.
Cat-back exhaust market to reach $6.24 billion by 2030
AGP
The cat-back exhaust market is forecast to grow from $4.58 billion in 2025 to $4.89 billion in 2026, then reach $6.24 billion by 2030, according to a new industry report.
Car laminated glass market seen reaching $10.61 billion by 2030
AGP
The Business Research Company says the global car laminated glass market is on track to grow from $7.21 billion in 2025 to $10.61 billion by 2030, driven by safety rules, rising vehicle production and more advanced windshield technology.
Ceric ammonium nitrate market seen rising to $540 million by 2030
AGP
The ceric ammonium nitrate market is projected to grow from $360 million in 2025 to $390 million in 2026, with demand supported by pharmaceuticals, semiconductors and chemical manufacturing.
Car sharing market seen reaching $12.85 billion by 2030
AGP
The Business Research Company says the global car sharing market is expanding quickly as urbanization, traffic congestion and demand for flexible mobility reshape how people move in cities.
Catalytic reforming catalyst market seen reaching $0.97B by 2030
AGP
The catalytic reforming catalyst market is projected to rise from $0.71 billion in 2025 to $0.97 billion by 2030, driven by stronger demand for high-octane fuels, refinery hydrogen and cleaner transportation fuels.
FCCSP package market seen growing to $7.19 billion by 2030
AGP
The flip chip CSP package market is projected to rise from $5.02 billion in 2026 to $7.19 billion by 2030, driven by demand for smaller, higher-performance semiconductor packaging.
Tenecteplase market forecast points to steady growth through 2030
AGP
The Tenecteplase (TNKase) market is forecast to rise from $1.78 million in 2025 to $1.89 million in 2026, with growth tied to stroke, myocardial infarction, and wider use of rapid clot-busting treatment.
Thrombate III market forecast points to steady growth through 2035
AGP
The Business Research Company says the global Thrombate III market is expanding on rising hemophilia cases, more surgeries and broader healthcare infrastructure.
Thymoglobulin market forecast points to faster growth through 2035
AGP
The Business Research Company says the global Thymoglobulin market is set to expand through 2035, driven by more organ transplants, rising autoimmune disease cases and broader use of antibody-based immunosuppressive therapies.
Tecartus market forecast points to growth through 2035
AGP
The Business Research Company says the Tecartus market is poised for continued expansion through 2035, driven by rising hematologic cancer cases, broader use of personalized medicine and more investment in CAR-T infrastructure.
Tepezza market forecast points to growth through 2035
AGP
The Business Research Company says the Tepezza market is expanding as thyroid eye disease diagnoses rise, infusion access broadens and interest grows in targeted autoimmune therapies.
Air traffic flow management market forecast to hit $49.73 billion by 2030
AGP
The global air traffic flow and capacity management market is projected to grow from $30.16 billion in 2026 to $49.73 billion by 2030, driven by rising passenger traffic, airport congestion and digital air traffic tools.
Survanta market forecast points to growth through 2030
AGP
The Survanta market is expanding as premature births rise and neonatal care improves, according to a new forecast from The Business Research Company.
Strimvelis market forecast points to growth through 2026
AGP
The Strimvelis gene therapy market is expected to expand through 2026 as rare disease diagnoses rise, healthcare spending increases and personalized medicine gains ground.
Ruconest market forecast points to faster growth through 2035
AGP
The Business Research Company says the Ruconest market is set to expand through 2035 as hereditary angioedema diagnosis rises, home infusion grows and rare-disease investment increases.
Repatha market forecast points to faster growth in Asia-Pacific
AGP
The Business Research Company says the Repatha market is set to expand through 2035, driven by rising cardiovascular disease, high cholesterol and obesity rates.
Chemotherapy-induced anemia market forecast to hit $4.13 billion by 2030
AGP
The chemotherapy-induced anemia market is projected to grow from $2.81 billion in 2025 to $4.13 billion by 2030, driven by more intensive cancer treatment, higher anemia rates and wider use of supportive care.
Rebyota market forecast points to growth through 2026
AGP
The Business Research Company says the Rebyota market is expected to expand as recurrent C. difficile infections, antibiotic use and microbiome research drive demand for microbiota-based therapies.
Rebif market forecast sees MS demand, aging populations drive growth
AGP
The Business Research Company says the global Rebif market is set to expand through 2035 as multiple sclerosis diagnoses rise, older populations grow and at-home injectable treatment demand increases.
Sign up for:
Market Forecast Analysis
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.